Codice QR

Omalizumab may protect allergic patients against COVID-19: A systematic review

Omalizumab, which downregulates the immunoglobulin E (IgE) receptor site on plasmacytoid dendritic cells and thereby increases interferon-α (INF-α) production, may shorten the duration of viral infections by enhancing the antiviral immunity.A systematic review was conducted to investigate whether pr...

Descrizione completa

Salvato in:
Autori principali: Daniele Giovanni Ghiglioni, MD, ET Laura Cozzi, MD, Riccardo Castagnoli, MD, PhD, Gaia Bruschi, MD, Laura Maffeis, MD, Paola Giovanna Marchisio, MD, Gian Luigi Marseglia, MD, Amelia Licari, MD, PhD
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2023-02-01
Serie:World Allergy Organization Journal
Soggetti:
COVID-19
Interferon
IFN-Alpha
Omalizumab
SARS-CoV-2
Accesso online:http://www.sciencedirect.com/science/article/pii/S1939455123000017
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi